This document is the cover page of a Cowen Equity Research report titled 'Cowen's Collective View of CBD,' dated February 25, 2019. The report provides market analysis and projections for the CBD industry, predicting $16 billion in sales by 2025, and highlights specific stocks (WEED, TLRY, TPB). While the content is strictly financial research, the document bears the Bates stamp 'HOUSE_OVERSIGHT_024817,' indicating it was collected as part of a House Oversight Committee investigation.
| Name | Role | Context |
|---|---|---|
| Vivien Azer | Analyst / Researcher |
Listed contact for Cowen Research on the report cover.
|
| Michael Cella | Recipient / Employee |
Named in the watermark text: 'This report is intended for michael.cella@cowen.com'.
|
| Name | Type | Context |
|---|---|---|
| Cowen |
Financial services firm publishing the report.
|
|
| Cowen Research |
Research division of Cowen.
|
|
| WEED |
Stock ticker symbol (Canopy Growth Corporation) mentioned as 'Outperform rated'.
|
|
| TLRY |
Stock ticker symbol (Tilray) mentioned as 'Outperform rated'.
|
|
| TPB |
Stock ticker symbol (Turning Point Brands) mentioned as 'Outperform rated'.
|
|
| House Oversight Committee |
Implied by the Bates stamp 'HOUSE_OVERSIGHT_024817'.
|
| Location | Context |
|---|---|
|
Mentioned in relation to the proprietary survey and CBD sales projections.
|
Complete text extracted from the document (863 characters)
Discussion 0
No comments yet
Be the first to share your thoughts on this epstein document